Background: Previous reports on racial disparities in the treatment of Crohn's disease [CD] [smoking], race remained a statistically significant factor in postoperative complication rate. Only after additional adjustment was made for comorbidities and American Society of Anesthesiologists class did race lose significance within our model. Conclusion: African Americans experience a greater amount of postoperative complications following surgery for Crohn's disease. Preoperative disease management, addressing smoking status and control of comorbid disease are important factors in addressing the racial disparities in the surgical treatment of Crohn's disease.
Introduction
Crohn's disease [CD] is a condition that frequently requires lifelong medical management with immunosuppressive medications. Intermittent flares may require hospitalization, and up to 70% of patients require intestinal surgery, with a majority of those requiring surgery requiring additional reoperations over their lifetime. 1 CD patients are at risk of short-gut syndrome after multiple operations, and patients with colorectal involvement are at increased risk for colorectal cancer compared with the general population. The clinical outcomes of this disease in African American [AA] patients have been described through examination of several single-institution studies that have shown that AA patients have an increased likelihood of presentation in the emergency room, and a decreased utilization of routine gastroenterology care, and may have an increased frequency of surgical management. [2] [3] [4] Indications for surgery in CD include perforation, enteric fistula, bleeding, malnutrition and obstruction. Typically, management of these conditions can be controlled through either outpatient or inpatient medical management, which often then allows for a planned elective procedure. However, emergency indications can arise. Examples of planned interventions that can increase the likelihood of good surgical outcomes include preoperative sepsis management with radiologically guided drain placement [s] and antibiotics, adequate time interval off immunosuppressant medications prior to surgery, and a period of nutritional support, when indicated, using total parenteral nutrition [TPN] .
Although current literature examining CD care in AA patients is sparse, there is a suggestion that chronic disease management may overall be of lower quality in these patients compared to non-AA patients. 4 Inadequate chronic disease management may put these patients at increased risk for unplanned and emergency procedures, thereby increasing the risk of major complications postoperatively. However, other risk factors for complications after intestinal surgery, such as comorbidities and active smoking, may also be more prevalent in AA patients undergoing surgery. We hypothesize that AA patients who undergo intestinal surgery for CD are at higher risk for postoperative major complications. We also hypothesize that AA patients are more likely to have preoperative sepsis, and undergo unplanned and emergency procedures with greater frequency than non-AA patients even when taking risk factors into account.
Methods
Using With respect to preoperative co-morbidities, preoperative sepsis was defined as preoperative systemic inflammatory response syndrome [SIRS] , sepsis or septic shock. Preoperative immunosuppressant medication was defined as the regular use of corticosteroid medication, or other immunosuppressive medications such as azathioprine, 6-mercaptopurine and tumour necrosis factor alpha [TNF-α] inhibitors, in the 30 days prior to surgery and excludes short course steroids. Preoperative weight loss was defined as >10% decrease in body weight in the 6 months prior to surgery. Cardiac disease was defined as history of congestive heart failure, myocardial infarction, angina within 1 month of surgery, percutaneous coronary intervention, or cardiac surgery. Chronic pulmonary disease was defined as dyspnoea with moderate exertion or at rest, or history of severe chronic obstructive pulmonary disease. Preoperative renal failure was defined as acute renal failure in the 24 h prior to surgery or preoperative acute or chronic haemodialysis. Ostomy procedures and laparoscopic procedures were defined by CPT codes, and queries for these procedures included primary, concurrent and other CPT code variable categories.
Outcome definitions
Our primary outcome was the occurrence of one or more major complication. Major complications included deep surgical site infection, organ-space infection [including intra-abdominal or pelvic abscess, or anastomotic leak], postoperative sepsis or septic shock, wound dehiscence, respiratory complications [pneumonia, failure to wean from the ventilator, unplanned reintubation], pulmonary embolism, cardiovascular complications [myocardial infarction, cardiac arrest, stroke], acute renal failure and coma greater than 24 h in duration.
Statistical analyses
We used the chi-squared test for categorical outcomes, and ANOVA for comparison of continuous outcomes between groups. Multivariable logistic regression was used to examine the association between surgical complications, race and risk factors. Several models were constructed to add clinically relevant variables and to adjust for important confounding variables. A broken arrow analysis was performed to account for the change of slope at age >45 years. Statistical analyses were performed in The R Project for Statistical Computing [The R Foundation].
Results
Our study sample of 9513 patients who underwent intestinal surgery for CD included 4390 [46.1%] men, and 790 [8.3%] African Americans. Patients were admitted preoperatively in 21.8% of cases, and 8.3% had preoperative sepsis, with 6.1% requiring emergency surgery. Ostomies were created in 20.3% of cases. The racial composition of the cohort is described in Table 1 . Compared with other races, AA patients were more likely to be smokers, to be admitted preoperatively, to be in preoperative sepsis and to be in preoperative renal failure. They were also more likely to be underweight [12.0% vs 7.3%] and obese [11.2% vs 10.8%] or morbidly obese [9.6% vs 6.8%]. The difference in proportions of having emergency surgery was not statistically significant between AA and non-AA patients. There was no difference in immunosuppressant medication use between racial groups, with 43% of patients overall using these prior to surgery. Twenty per cent of patients had a stoma created as part of surgery, and AA patients were more likely to have an ostomy [ Table 1 ]. They were no less likely to undergo laparoscopic surgery, which occurred in 26.7% of patients. Table 3 for all models].
Types of major complications are shown in 
Discussion
In this study, we have utilized a national surgical database, the ACS NSQIP PUF, to describe the absolute and relative rates of surgical complications following small or large bowel surgery in patients with CD. AA patients were more likely to have a postoperative complication compared to non-AA patients (23.5 and 18.9% [∆4.6%], respectively, p = 0.002). While they had higher rates of preoperative admission and sepsis, they did not, as we originally hypothesized, undergo a higher rate of emergency surgery. Aside from preoperative renal failure, AA patients did not have a significantly higher rate of comorbid disease. Interestingly, AA patients had a significantly higher rate of stoma formation, perhaps as a result of increased preoperative sepsis. The finding of AA patients experiencing more complications after surgical procedures compared to non-AA counterparts is not new. In 2006 Lucas found a 20% higher odds of operative mortality in AA versus white patients undergoing cardiothoracic or cancer surgeries using national Medicare data. 5 In our present analysis, preoperative disease severity decreased the impact of AA race on overall complication rate [OR 1.38 vs 1.27 when accounting for variables related to preoperative disease severity]. Although there was no difference in the rate of emergency surgery or preoperative immunosuppressant use between groups, AA patients did have increased rates of preoperative sepsis and >1 day preoperative admission prior to surgery. The reasons for this increase in preoperative disease severity among AA patients are probably multifactorial.
One potential reason for the increased rate of preoperative sepsis and preoperative admission in AA patients compared to other races could be an inherently more aggressive form of disease in AA patients. This has been suggested by several early studies of CD in AA patients. 6 However, in a 2008 review by Mahid et al., seven published studies and one unpublished series failed to show a difference in disease severity between AA and non-AA patients. 7 Since then, numerous other studies examining CD in AA patients using institutional registries also showed no difference in disease severity between AA and non-AA patients. 2, 4, 8 The question that must then be asked is whether AA patients are receiving lower quality medical management of CD, which predisposes them to non-ideal circumstances at the time of surgical resection. While Nguyen did not show a difference in overall immunosuppressive medication use between AA and white patients, there was a significant decrease among AA patients in the use of infliximab, a targeted biological therapy. 4 Flasar et al. showed a trend toward decreased infliximab use in AA patients, with AA patients being half as likely to be prescribed the drug. 9 Another large series in northern California showed no difference in infliximab initiation or discontinuation by race whatsoever.
9,10 AA patients may be referred for specialist care with less frequency than non-AA patients. Previous studies have shown decreased rates of referral of AA patient to specialists compared to white patients. 4 Whether AA patients are maximally optimized on medical therapy prior to surgery remains elusive.
It is worthwhile to note that we found a higher rate of ostomy formation in AA patients compared to non-AA patients [23.8% vs 19.8%, p = 0.011]. Straus et al. found similar results in their multiinstitutional review. 3 From our review of the literature, there has not been any other published data on the rates of ostomy formation in AA versus non-AA patients with CD. This in and of itself warrants further investigation. The reasoning behind this is unclear, and probably multifactorial. Notably, AA patients had increased rates of preoperative sepsis and it could be supposed that surgeons elected to place an ostomy in the face of a septic patient. This type of clinical reasoning is not available in our dataset, and reasons for this increase in stoma formation in AA patients remain purely speculative. Increased rates of ostomy formation in AA patients undergoing other colorectal procedures have been reported. Numerous studies have shown increased rates of stoma formation and anal sphinctersacrificing surgery in AA patients undergoing surgery for rectal cancer compared to non-AA patients. [17] [18] [19] Elucidating these factors in greater detail should be the focus of further studies on disparities within colorectal surgery.
Accounting for lifestyle factors such as smoking and BMI also decreased the impact of AA race on complication rate. Smoking is known to complicate both the surgical and the medical management of CD, and to increase both the rate and the severity of infectious complications following colorectal surgery. [20] [21] [22] Work by Midura et al. showed smoking status to be an independent predictor of anastomotic leak.
Despite adjustment for factors related to preoperative disease severity and lifestyle factors such as smoking and BMI, race continued to remain statistically significant in the determination of postoperative complication rate. Only after adjustment for comorbid disease and ASA class did race lose statistical significance. It is possible that the study was underpowered to detect a significant difference after accounting for all risk factors, despite our large cohort. This is the first study to utilize ACS NSQIP for health disparities research in CD. Unlike previous studies evaluating racial disparities in CD course and treatment, we were not limited to a single institutional database. We were able to find over 9000 patients with a diagnosis of CD who underwent a procedure of interest. Since ACS NSQIP includes patients undergoing surgery at a variety of academic and community hospitals under both emergency and elective conditions nationally, it may provide a better representation of outcomes for the general CD population undergoing surgery compared to studies limited to a single institution or irritable bowel disease [IBD] registry.
This study had several limitations. ACS NSQIP does not contain socioeconomic or insurance status of patients, both of which are important elements when conducting health disparities research. 23 Information about prior CD care, including gastroenterological/ medical management, previous endoscopy, pathology and radiology reports, and previous medications is limited along with information about subsequent surgeries and other information about CD natural history. We inferred disease severity based on immunosuppression, preoperative sepsis, preoperative admission prior to surgery, and emergency surgery. We are unable to adjust for volume of IBD-related surgery performed at each hospital, a factor that may be significant in CD-related postoperative outcomes. 24 Finally, complications are limited to the 30-day postoperative period, and complications including disease complications beyond this are not captured in the ACS NSQIP database.
Another valid point worth addressing is the issue of clinical relevance in the face of statistical significance when using large databases for retrospective analysis. Our study showed a difference between AA and non-AA patients in rate of postoperative sepsis of 4.3% and a difference in overall complication rate of 4.6%. This seemingly small difference of 4.3% and 4.6% between racial groups equates to one additional AA patient with a complication out of 20 compared to non-AA patients. It is our assessment that this is a clinically significant difference. Previous studies addressing racial disparities in surgical care have also published small, but meaningful. differences. Alavi et al. published an 11% difference in overall complication rates and a 2% difference in 30-day mortality between AA and white patients undergoing surgery for diverticulitis using the ACS NSQIP database. 25 Similarly, Sukumar et al. and Brooks Carthon et al. published separate studies showing differences in complication rates between AA and non-AA patients undergoing major surgery of 2.3% and 8%, respectively. 26, 27 Although small, these significant differences in surgical care based on racial group merit attention. Final judgment on the clinical relevance of these data from large national databases ultimately rests with the audience.
This initial study utilizing ACS NSQIP for CD disparities research agrees with other recent studies that have shown a higher rate of CD and CD-related surgery in the AA population in what was once assumed to be a disease limited to socioeconomically advantaged white patients. The reasons behind continued racial disparities in CD-related outcomes should be the focus of further research efforts. Meanwhile, appropriate medical management, adequate treatment of comorbid conditions, and addressing modifiable lifestyle factors such as smoking status and BMI should be areas of prioritization for further work in bridging the racial divide in the management and treatment of CD.
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